SELECTIVE PROPHYLAXIS OF RHINO-SINUSITIS IN CHILDREN WITH ACUTE RESPIRATORY VIRAL INFECTION
https://doi.org/10.15690/vsp.v11i2.220
Abstract
The results of treatment of 52 children with acute respiratory viral infections (ARVI) aged from 4 to 10 years were studied based on
observation diaries, filled by parents, and data of the otorhinolaryngologists examinations on the 7th and 10th days from the onset of the disease. The children were divided into 2 groups: 1 group consisted of 30 children, which were treated with Sinupret monotherapy; 2 group consisted of 22 children, which were treated with endonasal irrigation, decongestants and antiseptics. The parallel analysis of the treatment results of children with ARVI showed, that Sinupret is well-tolerated by patients, contributes to milder course of the disease. Due to its anti-inflammatory and anti-viral actions this drug prevents development of such complications of respiratory tract infections as acute purulent rhino-sinusitis and acute otitis media. Sinupret also precipitates the processes of convalescence on 45% at the average and shorten the prolongation of disease on 5 days at the average, so it can be recommended to be included into the standard protocol of treatment children with ARVI.
observation diaries, filled by parents, and data of the otorhinolaryngologists examinations on the 7th and 10th days from the onset of the disease. The children were divided into 2 groups: 1 group consisted of 30 children, which were treated with Sinupret monotherapy; 2 group consisted of 22 children, which were treated with endonasal irrigation, decongestants and antiseptics. The parallel analysis of the treatment results of children with ARVI showed, that Sinupret is well-tolerated by patients, contributes to milder course of the disease. Due to its anti-inflammatory and anti-viral actions this drug prevents development of such complications of respiratory tract infections as acute purulent rhino-sinusitis and acute otitis media. Sinupret also precipitates the processes of convalescence on 45% at the average and shorten the prolongation of disease on 5 days at the average, so it can be recommended to be included into the standard protocol of treatment children with ARVI.
About the Authors
Tamara Aleksandrovna Mashkova
Voronezh N.N. Burdenko State Medical Academy
Russian Federation
Tamara Aleksandrovna Mashkova, PhD, professor, Head of the Department of Otolaryngology of N.N. Burdenko Voronezh State Medical Academy
Russian Federation
Tamara Aleksandrovna Mashkova, PhD, professor, Head of the Department of Otolaryngology of N.N. Burdenko Voronezh State Medical Academy
A. B. Maltsev
Voronezh N.N. Burdenko State Medical Academy
Russian Federation
Russian Federation
References
1. Пискунов Г. З., Пискунов С. З. Клиническая ринология. М.: МИКЛОШ. 2002. 390 с.
2. Biebach K., Kramer A. Effektive Behndlung der Rhinosinusitis bei Kinder. Praktisch Padiatrie, Sonderdruck aus pad. 2004; 10: 3–8.
3. Карпова Е. П., Усеня Л. Н., Байкова В. Н. и соавт. Особенности системы антиоксидантной защиты у детей с хроническим гнойным верхнечелюстным синуситом и ее коррекция. Российская оториноларингология. 2004; 6: 67–70.
4. Kaliner M. A. Recurrent Sinusitis Examining Medical Treatment Options. American Journal of Rhinology. 1997; 11: 123–132.
5. Полякова Т. С., Владимирова В. В. Вестник оториноларингологии. 2001; 2: 50–51.
6. Смирнова Г. И. Опыт применения Синупрета и Тонзилгона для профилактики и лечения острых респираторных заболеваний у часто болеющих детей. Детский доктор. 2001; 4: 25–29.
7. Шахова Е. Г., Малова Т. В. Синупрет в комплексной терапии воспалительных заболеваний околоносовых пазух. Российская оториноларингология. 2005; 3: 89–91.
Review
For citations:
Mashkova T.A., Maltsev A.B. SELECTIVE PROPHYLAXIS OF RHINO-SINUSITIS IN CHILDREN WITH ACUTE RESPIRATORY VIRAL INFECTION. Current Pediatrics. 2012;11(2):106-108. (In Russ.) https://doi.org/10.15690/vsp.v11i2.220
Views:
741
Email this article 
